Business as usual?

Detalhes bibliográficos
Autor(a) principal: Pereira, Diogo Teixeira
Data de Publicação: 2023
Outros Autores: Moury, Catherine, Barros, Pedro Pita
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/159665
Resumo: This work was funded by Fundação para a Ciência e a Tecnologia (UIDB/00124/2020, UIDP/00124/2020 and Social Sciences DataLab – PINFRA/22209/2016), POR Lisboa and POR Norte (Social Sciences DataLab, PINFRA/22209/2016).
id RCAP_2947aa7bbf04d967a57a2baffe399f66
oai_identifier_str oai:run.unl.pt:10362/159665
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Business as usual?How the pharmaceutical industry protected its long-term interests during and after eurozone bailouts (2011–2020)Eurozone crisisPharmaceutical industryLobbyRentsState-industry agreementsThis work was funded by Fundação para a Ciência e a Tecnologia (UIDB/00124/2020, UIDP/00124/2020 and Social Sciences DataLab – PINFRA/22209/2016), POR Lisboa and POR Norte (Social Sciences DataLab, PINFRA/22209/2016).In this article, we start from the assumption that the pharmaceutical industry accumulates material, instrumental, ideational and institutional power. Considering this, we expect that it would be very difficult for governments to reduce the rents of pharmaceutical companies in the long-term, even when the former are externally constrained to reduce their spending. We test our argument by carrying out a qualitative analysis of a paradigmatic case study, the Portuguese economic adjustment programme (2011–2014). We demonstrate that the conditionality associated with the international bailout was welcomed by Portuguese reformist ministers as an opportunity to decrease public pharmaceutical spending. However, the representatives of the industry took several initiatives to make sure that the decrease of its profits would be limited in scope and time. As a result, as soon as the bailout terminated, the industry was able to regain its rents.Departamento de Estudos Políticos (DEPo)NOVA School of Business and Economics (NOVA SBE)RUNPereira, Diogo TeixeiraMoury, CatherineBarros, Pedro Pita2023-11-07T22:08:12Z2023-03-292023-03-29T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/159665eng2474-736XPURE: 58571790https://doi.org/10.1080/2474736X.2023.2193622info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:42:06Zoai:run.unl.pt:10362/159665Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:57:38.481649Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Business as usual?
How the pharmaceutical industry protected its long-term interests during and after eurozone bailouts (2011–2020)
title Business as usual?
spellingShingle Business as usual?
Pereira, Diogo Teixeira
Eurozone crisis
Pharmaceutical industry
Lobby
Rents
State-industry agreements
title_short Business as usual?
title_full Business as usual?
title_fullStr Business as usual?
title_full_unstemmed Business as usual?
title_sort Business as usual?
author Pereira, Diogo Teixeira
author_facet Pereira, Diogo Teixeira
Moury, Catherine
Barros, Pedro Pita
author_role author
author2 Moury, Catherine
Barros, Pedro Pita
author2_role author
author
dc.contributor.none.fl_str_mv Departamento de Estudos Políticos (DEPo)
NOVA School of Business and Economics (NOVA SBE)
RUN
dc.contributor.author.fl_str_mv Pereira, Diogo Teixeira
Moury, Catherine
Barros, Pedro Pita
dc.subject.por.fl_str_mv Eurozone crisis
Pharmaceutical industry
Lobby
Rents
State-industry agreements
topic Eurozone crisis
Pharmaceutical industry
Lobby
Rents
State-industry agreements
description This work was funded by Fundação para a Ciência e a Tecnologia (UIDB/00124/2020, UIDP/00124/2020 and Social Sciences DataLab – PINFRA/22209/2016), POR Lisboa and POR Norte (Social Sciences DataLab, PINFRA/22209/2016).
publishDate 2023
dc.date.none.fl_str_mv 2023-11-07T22:08:12Z
2023-03-29
2023-03-29T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/159665
url http://hdl.handle.net/10362/159665
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2474-736X
PURE: 58571790
https://doi.org/10.1080/2474736X.2023.2193622
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138158793719808

Registros relacionados